Compare UBC Medical Indonesia Tbk. (LABS) vs Semen Indonesia (Persero) Tbk. (SMGR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
UBC Medical Indonesia Tbk. vs Semen Indonesia (Persero) Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 651.75B), while Semen Indonesia (Persero) Tbk. trades at Rp1,510 (market cap 10.19T). The key difference: Semen Indonesia (Persero) Tbk. is far larger — about 15.6× UBC Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| LABS | SMGR | |
|---|---|---|
Market Cap | 651.75B | 10.19T |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →About Semen Indonesia (Persero) Tbk.
PT Semen Indonesia (Persero) Tbk was established on March 25,1953 as NV Pabrik Semen Gresik. On April 17, 1961,NV Pabrik Semen Gresik was transformed into a state enterprise (Persero) by Government Regulation No. 132 year 1961, and subsequently became PT Semen Gresik (Persero). Semen Gresik is a cement producer which was formerly fully owned by the government. On July 1995 the company shareholders meeting agreed to acquired 100% share of two state owned cement producer companies, namely PT. Semen Tonasa and PT. Semen Padang.
Read more on SMGR →
